Archive for July, 2009

A genome wide search for genes underlying anxiety disorders turned up unexpected candidates July 24, 2009

Increasing the activity of two enzymes better known for their role in oxidative stress metabolism turns normally relaxed mice into “Nervous Nellies,” according to research conducted at the Salk Institute for Biological Studies and reported in the early online edition of Nature.
Locally overexpressing either glyoxalase 1 or glutathione reductase 1 in mouse brains [...]

Major Study Begins Into Work-Related Health And Well-Being July 21, 2009

A study that could improve our health and well-being at work is about to start at The University of Nottingham.
In 2006 and 2007 more than half a million individuals in Britain reported experiencing work-related stress at a level that was making them ill.
Dr Maria Karanika-Murray, a Research Fellow in Occupational Health [...]

Study On Antioxidants And Memory Concerns Underway At Rush University Medical Center

Rush University Medical Center is conducting a clinical trial to evaluate whether taking Cerefolin®NAC reduces the inflammation and oxidative stress that is associated with memory decline in older persons. Cerefolin NAC is a commercially available food supplement available by prescription. It is a combination of high dose vitamin B12, B6, and folic acid along with [...]

Stress, Anxiety Can Make Allergy Attacks Even More Miserable, Last Longer July 20, 2009

A new study here shows that even slight stress and anxiety can substantially worsen a person’s allergic reaction to some routine allergens.
Moreover, the added impact of stress and anxiety seem to linger, causing the second day of a stressed person’s allergy attack to be much worse.
The finding, the latest in more than three [...]

Eli Lilly And Company Introduces Reconcile(TM) For Separation Anxiety In Dogs July 19, 2009

Eli Lilly and Company (NYSE: LLY) announced today it has received approval from the FDA to market Reconcile(TM) (fluoxetine hydrochloride), the first selective serotonin reuptake inhibitor (SSRI) class of antidepressants approved by the FDA for treatment of canine separation anxiety in conjunction with behavior modification training. Reconcile(TM) is the first Lilly product approved by the [...]

Phobias and sudden cardiac death link

Women who have high levels of phobic anxiety have a higher chance of developing fatal coronary heart disease and sudden cardiac death.
This is according to one of the speakers at the American Heart Association’s 44th Annual Conference on Cardiovascular Disease Epidemiology and Prevention conference, San Francisco, USA.
Delegates were told of research [...]

Spanish Study Of Women And Cigarettes July 17, 2009

A study carried out at the Department of Anthropology of the University of Granada has examined, both at a quantitative and a qualitative level, the reasons for the increase in the use of cigarettes among women experienced in Spanish society during the last 50 years. One of the main conclusions of this study is that [...]

US Vets With PTSD Not Getting Equal And Fair Compensation From VA, Says New Report July 15, 2009

The current method for making sure former US military personnel with service-connected post-traumatic stress disorder (PTSD) get fair and equal disability compensation from the US Department of Veterans Affairs (VA) is not working and should be revised according to a new report from the Institute of Medicine and National Research Council.
The study was commissioned [...]

Combat Stress Linked To Heart Disease In Later Life July 14, 2009

A study of combat veterans living in Greater Boston, Massachusetts has found a link between post traumatic stress severity and increased risk of coronary heart disease in older men.
The study is published in the Archives of General Psychiatry and was conducted by scientists from the Harvard School of Public Health with the collaboration of [...]

Evidence Lacking To Support Many Off-Label Uses Of Atypical Antipsychotics

Some newer antipsychotic medications approved to treat schizophrenia and bipolar disorder are being prescribed to millions of Americans for depression, dementia, and other psychiatric disorders without strong evidence that such off-label uses are effective, according to a new analysis by HHS’ Agency for Healthcare Research and Quality.
The federally funded comparative effectiveness review of these [...]